RLMD insider buying
Every open-market purchase of Relmada Therapeutics, Inc. (RLMD) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$4.03M
Insiders buying (12m)4
Purchases on record8
Last purchase filedSep 11, 2026
In the last 12 months, 4 insiders of Relmada Therapeutics, Inc. bought $4.03M of RLMD stock on the open market in 8 reported purchases. The most recent was filed on Sep 11, 2026: Shenouda Maged (Chief Financial Officer) bought 200,000 shares at $4.22, worth $843.99K. The largest purchase on record here is $1.10M by Shenouda Maged on Nov 5, 2025.
Get the next RLMD insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll RLMD insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Sep 11 | Shenouda MagedChief Financial Officer | $843.99K | 200,000 | $4.22 | +28% | Sep 9 | SEC |
| Sep 11 | Traversa SergioChief Executive Officer, Director | $828K | 200,000 | $4.14 | +15% | Sep 9 | SEC |
| Dec 16 | Traversa SergioChief Executive Officer, Director | $113.30K | 27,500 | $4.12 | +2% | Dec 15 | SEC |
| Dec 16 | Shenouda MagedChief Financial Officer | $48.06K | 11,665 | $4.12 | +2% | Dec 15 | SEC |
| Nov 6 | Ence ChuckCAO and COO | $299.20K | 136,000 | $2.20 | +51% | Nov 5 | SEC |
| Nov 6 | Traversa SergioChief Executive Officer, Director | $599.50K | 272,500 | $2.20 | +27% | Nov 5 | SEC |
| Nov 6 | Shenouda MagedChief Financial Officer | $1.10M | 500,000 | $2.20 | +173% | Nov 5 | SEC |
| Nov 6 | Kelly Paul EdwardChief Operating Officer, Director | $198K | 90,000 | $2.20 | +22% | Nov 5 | SEC |